慢性乙型肝炎重度患者树突状细胞的分化和功能研究
摘要
慢性乙型肝炎是我国最常见的传染病,也是预后较差的一种疾病。对慢性乙型肝炎发病机制和治疗的研究一直是一个热点。树突状细胞(DC)是已知功能最强的专职抗原呈递细胞,DC表达的主要组织相容性复合体(MHC)Ⅰ、MHCⅡ类分子、共刺激分子以及DC分泌的IFN-7、IL-12、IL-18等细胞因子,反映了DC的分化成熟程度。我们利用IL-10、TNF-α、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和IL-4分别培养健康对照者和慢性乙型肝炎重度患者外周静脉血的贴壁单核细胞,
出处
《中华传染病杂志》
CAS
CSCD
北大核心
2010年第10期620-623,共4页
Chinese Journal of Infectious Diseases
参考文献9
-
1Lamhamedi-Cherradi SE,Martin RE,Ito T,et al.Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12.J Immunol,2008,180:6000-6009.
-
2中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
-
3Cools N,Van Tendeloo VF,Smits EL,et al.Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+regulatory T cells.J Cell Mol Med,2008,12:690-700.
-
4Li M,Zhang X,Zheng X,et al.Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.Int Immunol,2008,20:285-293.
-
5Op den Brouw ML,Binda RS,van Roosmalen MH,et al.Hepatitis B virus surface antigen impairs myeloid dendritic cell function:a possible immune escape mechanism of hepatitis B virus.Immunology,2009,126:280-289.
-
6Zhang Z,Zou ZS,Fu JL,et al.Severe dendritic cell perturbation is actively involved in the pathogenesis of acuteon-chronic hepatitis B liver failure.J Hepatol,2008,49:396-406.
-
7Chen W,Shi M,Shi F,et al.HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes.Hepatol Res,2009,39:355-365.
-
8Chen W,Zhang Z,Shi M,et al.Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.Clin Immunol,2008,129:295-303.
-
9石庆凤,曾维群,陈敏,石统东,彭明利,胡鹏,胡怀东,陈学华,孙航,郭晖,唐开福,刘杞,任红.IL-10、TNF-α对慢性乙型肝炎患者树突状细胞的影响[J].免疫学杂志,2009,25(3):311-313. 被引量:7
二级参考文献8
-
1[1]Eichler H,Nguyen XD,Roden D,et al.Multicenter study on in vitro characterization ofdendritic cells[J].Cytotherapy,2008,10(1):21-29.
-
2[2]Castellano G,Woltman AM,Schlagwein N,et al.Immune modulation of human dendritic cells by complement[J].Eur J Immunol,2007,37(10):2 803-2 811.
-
3[5]Jarnjak Jankovic S,Saeboe Larssen S,Kvalheim G,et al.mRNA transfection of DC in the immature or mature state:comparable in vitro priming of Th and cytotoxic T lymphocytes against DC ekctroporated with tumor cell line-derived mRNA[J].Cytotherapy,2007,9(6):587-592.
-
4[6]Sousa Canavez JM,Canavez FC,Leite KR,et al.Tlierapeu tic Dendritic cell vaccine preparation using tumor RNA trans-fection:A promise approach to treat prostate cancer[J].Genet Vaccines Ther,2008,6(1):2.
-
5[7]Royer PJ,Bougras G,Ebstein F,et al.Efficient monocyte derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment:Application to active immunotherapy[J].Exp Hematol,2008,36(3):329-339.
-
6[8]Castellano G,Woltman AM,Schlagwein N,et al.Immune modulation of human dendritic cells by complement[J].Eur J Immunol,2007,37(10):2 803-2 811.
-
7[9]Mende I,Engleman EG..Breaking self-tolerance to tumor associated antigens by in vivo manipulation of dendritic cells[J].Methods Mol Biol,2007,380:457-468.
-
8李用国,陈敏,张大志,王志毅,曾维群,石小枫,郭渊,郭树华,任红.自体树突状细胞疫苗治疗慢性乙型肝炎的临床研究[J].中华肝脏病杂志,2003,11(4):206-208. 被引量:41
共引文献14015
-
1刘洋.复方木鸡颗粒联合替诺福韦治疗代偿期乙型肝炎肝硬化患者的临床研究[J].慢性病学杂志,2019,0(12):1853-1854.
-
2李钊,黄宛香,李繁.乙型肝炎病毒感染肝硬化AST/ALT和LSM值与Child-Pugh分级及临床分期关系[J].热带医学杂志,2023,23(11):1593-1596.
-
3曾远松,黄柳春.茵郁芪灵汤联合恩替卡韦治疗慢性乙型肝炎的疗效观察[J].内蒙古中医药,2021,40(5):13-14. 被引量:2
-
4宫笑一,刘守华.代偿期乙肝肝硬化患者服用恩替卡韦对血清甲状腺激素水平的影响[J].中国农村卫生,2018,0(16):78-78.
-
5王雪艳,张旭东.甘草酸二铵对乙肝肝硬化患者TBIL、CⅣ及炎性因子的影响分析[J].医药论坛杂志,2021,42(16):7-10.
-
6欧阳福生.老年病毒性肝炎267例临床报告[J].山东大学学报(医学版),2014,52(S01):83-84.
-
7潘晓华.阿德福韦酯联合拉米夫定治疗乙肝肝硬化患者80例8年的临床报道[J].世界最新医学信息文摘,2020(48):108-109.
-
8付振双.恩替卡韦治疗失代偿期慢性乙型病毒性肝炎肝硬化的临床研究[J].世界最新医学信息文摘,2020(2):150-150. 被引量:1
-
9陈新梅,陈昆迪.重型肝病转归与季节关系的探讨[J].医学信息,2018,31(A02):62-63.
-
10王同兴,于卫叶.联合检测血清PCⅢ,HA,LN对肝纤维化的诊断价值[J].医学信息(医学与计算机应用),2016,29(28):217-218. 被引量:2
-
1付洪彦,朱明智,赵琰.苦黄注射液治疗慢性乙型肝炎重度30例疗效观察[J].中国新医药,2004,3(6):107-107.
-
2黎志良,李金庚.中草药茵陈汤治疗115例慢性乙型肝炎重度疗效评价[J].肝脏,2011,16(4):355-356. 被引量:4
-
3李玉姝,于晓会,滕晓春,关海霞,范晨玲,单忠艳,滕卫平.表达MHCⅡ类分子的转基因鼠甲状腺细胞对自身T细胞的影响[J].中华内分泌代谢杂志,2009,25(3):278-279.
-
4薛云平,温志立,黄神安,袁小亮.激素治疗慢性乙型肝炎重度伴胆汁淤积1例[J].肝脏,2009,14(4):339-339.
-
5袁海宁,邓一鸣,吴健林.益气健脾方剂治疗慢性乙型肝炎重度患者的临床观察[J].广西医科大学学报,2006,23(2):303-304. 被引量:2
-
6李艳,戚好文.支气管哮喘与免疫调节[J].国际呼吸杂志,2008,28(7):400-402. 被引量:2
-
7陈从新,刘波,郭顺明,杨家宏,刘克万,徐宁.苦参碱治疗慢性乙型肝炎重度患者的临床对照观察[J].肝脏,2007,12(4):289-290. 被引量:2
-
8孙德利,陈汉平,吴焕淦,王月芳,陈海英,郑东升.天灸对小鼠造血功能的影响及其机理的探讨[J].针刺研究,1999,24(3):206-211. 被引量:9
-
9周贤清.复正软肝颗粒治疗肝纤维化的临床研究[J].中西医结合肝病杂志,2001,11(6):335-336. 被引量:1
-
10吴东刚,何文涛.促肝细胞生长素联合舒肝宁治疗慢性乙型肝炎重度疗效观察[J].实用肝脏病杂志,2012,15(6):574-575. 被引量:6